Alexandria Real Estate Equities
ARE
#2169
Rank
โ‚น835.83 B
Marketcap
โ‚น4,823
Share price
-2.61%
Change (1 day)
-43.90%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -โ‚น89.1 Billion

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚น2.94 Billion. a decrease over its 2024 earnings that were of โ‚น63.83 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 -โ‚น90.73 Billion-242.13%
2024 โ‚น63.83 B96.11%
2023 โ‚น32.55 B-53.56%
2022 โ‚น70.09 B-3.96%
2021 โ‚น72.98 B-20.26%
2020 โ‚น91.52 B72.88%
2019 โ‚น52.94 B3.11%
2018 โ‚น51.34 B73.54%
2017 โ‚น29.58 B464.88%
2016 โ‚น5.23 B-77.32%
2015 โ‚น23.09 B36.31%
2014 โ‚น16.93 B-10.81%
2013 โ‚น18.99 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.086 T-1,297.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.062 T-2,373.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น755.48 B-932.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น905.96 B-1,098.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚น91.18 B-200.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น736.15 B-911.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น11.94 B-113.16%๐Ÿ‡บ๐Ÿ‡ธ USA